Merging microfluidics with luminescence immunoassays for urgent point-of-care diagnostics of COVID-19

The Coronavirus disease 2019 (COVID-19) outbreak has urged the establishment of a global-wide rapid diagnostic system. Current widely-used tests for COVID-19 include nucleic acid assays, immunoassays, and radiological imaging. Immunoassays play an irreplaceable role in rapidly diagnosing COVID-19 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Huijuan, Chen, Peng, Wan, Chao, Li, Yiwei, Liu, Bi-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637550/
https://www.ncbi.nlm.nih.gov/pubmed/36373139
http://dx.doi.org/10.1016/j.trac.2022.116814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637550/
https://www.ncbi.nlm.nih.gov/pubmed/36373139
http://dx.doi.org/10.1016/j.trac.2022.116814

Ejemplares similares